Journal of Thrombosis and Haemostasis · 2023 · 19 citations · 35 references
MedicineHematologyOncologyCancer ScreeningHematologic OncologyMolecular OncologyCancer BiomarkersDeep Vein ThrombosisThromboembolic DiseaseThrombosisThrombotic DisordersVenous ThromboembolismBlood-based BiomarkersCirculating Cell-free Dna AnalysisNeutrophil Extracellular Trap FormationOccult MalignancyPeripheral Blood Immune BiomarkersThrombosis BiomarkersThrombotic Risk AssessmentVenous Thromboembolism Biomarkers
BACKGROUND: Venous thromboembolism (VTE), particularly unprovoked VTE, is associated with occult cancer. The optimal screening regimen remains controversial. Neutrophil extracellular traps (NETs) are implicated in cancer-associated thrombosis, and elevated biomarkers of NET formation are associated with poor prognosis. OBJECTIVES: To investigate the association between NET formation and occult cancer in patients with VTE. METHODS: Blood biomarkers associated with NETs and neutrophil activation (nucleosomal citrullinated histone H3 [H3Cit-DNA], cell-free DNA, and neutrophil elastase) were quantified in patients with VTE. The primary outcome was cancer diagnosed during a one-year follow-up. RESULTS: This study included 460 patients with VTE, of which 221 (48%) had isolated deep vein thrombosis. Forty-three patients had active cancer at inclusion and were excluded from the primary analysis Cancer during follow-up was diagnosed in 29 of 417 (7.0%) patients. After adjustment for age and unprovoked VTE, the hazard ratio of cancer during follow-up per 500 ng/mL increase of H3Cit-DNA was 1.79 (95% CI, 1.03-3.10). Furthermore, patients with cancer-associated VTE (known active cancer or cancer diagnosed during follow-up) had higher levels of H3Cit-DNA than cancer-free patients with VTE after adjustment for age, hemoglobin, gender, chronic obstructive pulmonary disease, previous cancer, and start of anticoagulant treatment (odds ratio 2.06 per 500 ng/mL increase of H3Cit-DNA [95% CI, 1.35-3.13]). CONCLUSIONS: H3Cit-DNA is an independent predictor for occult cancer in patients with VTE and elevated in cancer-associated VTE, suggesting that H3Cit-DNA is potentially a useful diagnostic marker for cancer in patients with VTE and that elevated NET formation is a hallmark of cancer-associated VTE.
35
Neutrophil Extracellular Traps Kill Bacteria
Volker Brinkmann, Ulrike Reichard, Christian Goosmann et al. · Science · 2004 · 10.1K citations
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang et al. · Science · 2018 · 2.8K citations
Medicine, Oncology, Cancer Screening +16
Mélanie Demers, Daniela S. Krause, Daphne Schatzberg et al. · Proceedings of the National Academy of Sciences · 2012 · 873 citations · Full text
Venous thromboembolism in cancer patients: a population-based cohort study
Frits I. Mulder, Erzsébet Horváth–Puhó, Nick van Es et al. · Blood · 2020 · 702 citations · Full text
Medicine, Hematology, Oncology +14
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde et al. · Science · 2020 · 663 citations · Full text